Vanderbilt University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1873-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vanderbilt.edu
Hydroxychloroquine in Cystic Fibrosis
Phase 1
Completed
- Conditions
- Cystic Fibrosis
- First Posted Date
- 2006-04-06
- Last Posted Date
- 2008-01-30
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 20
- Registration Number
- NCT00311883
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)
Phase 2
Completed
- Conditions
- Chronic Kidney Disease
- Interventions
- First Posted Date
- 2006-03-30
- Last Posted Date
- 2009-07-09
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 62
- Registration Number
- NCT00308971
- Locations
- 🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?
Phase 4
Completed
- Conditions
- Schizoaffective DisorderSchizophrenia
- Interventions
- Drug: divalproex sodium ERDrug: placebo
- First Posted Date
- 2006-03-23
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 60
- Registration Number
- NCT00306475
- Locations
- 🇺🇸
Psychiatric Hospital at Vanderbilt, Nashville, Tennessee, United States
Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation
Phase 4
Completed
- Conditions
- Kidney Transplantation
- First Posted Date
- 2006-03-21
- Last Posted Date
- 2006-03-21
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 80
- Registration Number
- NCT00305396
- Locations
- 🇺🇸
Vanderbilt University Medical Center/Nashville VA, Nashville, Tennessee, United States
Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging
Not Applicable
Completed
- Conditions
- Schizoaffective DisorderHallucinationsSchizophrenia
- Interventions
- Device: functional magnetic resonance imaging
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2017-04-19
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 60
- Registration Number
- NCT00288340
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Prevalence of Spasticity in Adults With Mental Retardation Living in the Community
Completed
- Conditions
- Mental RetardationSpasticity
- First Posted Date
- 2006-01-25
- Last Posted Date
- 2008-03-28
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 7
- Registration Number
- NCT00282191
- Locations
- 🇺🇸
Homes, Davidson County, Tennessee, United States
Center for Reducing Asthma Disparities - Meharry/Vanderbilt Centers
Completed
- Conditions
- AsthmaLung Diseases
- First Posted Date
- 2006-01-24
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 180
- Registration Number
- NCT00281151
- Locations
- 🇺🇸
Meharry Medical School, Nashville, Tennessee, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
Botox vs. Baclofen for Upper Limb Spasticity
Phase 1
Terminated
- Conditions
- Spasticity
- Interventions
- Drug: intramuscular Botox versus oral baclofen
- First Posted Date
- 2006-01-20
- Last Posted Date
- 2012-01-20
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 8
- Registration Number
- NCT00280280
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Selenium Supplementation of Patients With Cirrhosis
Not Applicable
Terminated
- Conditions
- Liver Disease
- Interventions
- Dietary Supplement: 200 µg selenium as selenateDietary Supplement: 400 µg selenium as selenateDietary Supplement: 200 µg selenium as selenomethionineDietary Supplement: Placebo
- First Posted Date
- 2005-12-30
- Last Posted Date
- 2012-03-07
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 99
- Registration Number
- NCT00271245
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Omentectomy for the Treatment of Diabetes Mellitus Type 2
Phase 1
Completed
- Conditions
- Diabetes Mellitus Type 2DyslipidemiaHypercholesterolemiaObesity
- Interventions
- Procedure: removal of omentum
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2009-09-14
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 10
- Registration Number
- NCT00270439
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath